Kurzrock, R., Ball, D. W., Zahurak, M. L., Nelkin, B. D., Subbiah, V., Ahmed, S., . . . Azad, N. S. (2019). A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers. Clin Cancer Res.
Citação norma ChicagoKurzrock, Razelle, et al. "A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination With the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers." Clin Cancer Res 2019.
Deismireacht MLAKurzrock, Razelle, et al. "A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination With the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers." Clin Cancer Res 2019.